These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 29878845

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH, Cai JJ, She ZG, Li HL.
    World J Gastroenterol; 2019 Mar 21; 25(11):1307-1326. PubMed ID: 30918425
    [Abstract] [Full Text] [Related]

  • 25. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ, Earnest A, Kemp WW, Burton PR, Laurie C, Majeed A, Johnson N, McLean C, Roberts SK, Brown WA.
    Int J Obes (Lond); 2018 Nov 21; 42(11):1900-1911. PubMed ID: 29463916
    [Abstract] [Full Text] [Related]

  • 26. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN, Papatheodoridis GV, Ioannidou P, Deutsch M, Alexopoulou A, Papadopoulos N, Papageorgiou MV, Fragopoulou E, Kontogianni MD.
    Br J Nutr; 2018 Jul 21; 120(2):164-175. PubMed ID: 29947322
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. GDF11 induces mild hepatic fibrosis independent of metabolic health.
    Frohlich J, Kovacovicova K, Mazza T, Emma MR, Cabibi D, Foti M, Sobolewski C, Oben JA, Peyrou M, Villarroya F, Soresi M, Rezzani R, Cervello M, Bonomini F, Alisi A, Vinciguerra M.
    Aging (Albany NY); 2020 Oct 28; 12(20):20024-20046. PubMed ID: 33126224
    [Abstract] [Full Text] [Related]

  • 37. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S, Tanaka K, Tsujimoto T, So R, Shida T, Shoda J.
    Metab Syndr Relat Disord; 2014 Jun 28; 12(5):290-8. PubMed ID: 24689911
    [Abstract] [Full Text] [Related]

  • 38. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG, Mandato C, Poeta M, Vajro P.
    World J Gastroenterol; 2016 Sep 28; 22(36):8078-93. PubMed ID: 27688650
    [Abstract] [Full Text] [Related]

  • 39. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
    Abenavoli L, Luigiano C, Guzzi PH, Milic N, Morace C, Stelitano L, Consolo P, Miraglia S, Fagoonee S, Virgilio C, Luzza F, De Lorenzo A, Pellicano R.
    Panminerva Med; 2014 Jun 28; 56(2):189-93. PubMed ID: 24994581
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.